Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Yu Kanemaru(Niigata University), Yukihiko Fujii(Niigata University)
Acta Neuropathologica Communications
July 25, 2019
Cited by 69


Related Papers